Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment Category: NewsBy terrysheproApril 20, 2020Post navigationPreviousPrevious post:Paycheck Protection Program Out Of Funds, But Could Be ExtendedNextNext post:COVID-19 vaccine trackerRelated PostsDelta Cutting ‘Like a Buzzsaw’ Through Oregon-California Border CountiesAugust 31, 2021To Quarantine or Not: The Hard Choices Schools Are Leaving to Parents and StaffAugust 31, 2021Journalists Discuss Long Covid, Delta Variant, Clinic for MigrantsJuly 5, 2021‘An Arm and a Leg’: Tips for Fighting Medical Bills from ProPublica’s Marshall AllenJuly 5, 2021Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?July 5, 2021Rural Ambulance Services Are in Jeopardy as Volunteers Age and Expenses MountJuly 5, 2021
